BETonMACE timeline showed mid 2019 completion, but the presentation contained no details regarding enrollment, status of inclusion of US patients, or changes to the BETonMACE protocol. Perhaps the delay in hitting 125 events is the reason they revised the completion timeline. 

Renal and Fabry trials referred to as Phase 2b on one slide and Phase 2a on another. ClinicalTrials.gov lists them as Phase 1/2 trials and they have yet to begin Phase 1 portion as far as I know.